Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity

Gastroenterology

Volumn 153, Issue 3, 2017, Pages 743-752

  Schwarz, Jean Marc ^a,b   Noworolski, Susan M ^c   Erkin Cakmak, Ayca ^c   Korn, Natalie J ^c   Wen, Michael J ^b   Tai, Viva W ^c   Jones, Grace M ^a   Palii, Sergiu P ^a   Velasco Alin, Moises ^a,b   Pan, Karen ^b   Patterson, Bruce W ^d   Gugliucci, Alejandro ^a   Lustig, Robert H ^c   Mulligan, Kathleen ^a,b  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dietary Treatment; NAFLD; Overweight; Pediatric

Indexed keywords

1 ACETATE C 13; CARBOHYDRATE; FAT; FRUCTOSE; GLUCOSE; INSULIN; RADIOPHARMACEUTICAL AGENT; STABLE ISOTOPE; STARCH; SUGAR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CARBOHYDRATE DIET;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BODY FAT; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; CHILD; CHILD NUTRITION; CHILDHOOD OBESITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FAT CONTENT; FEMALE; FOLLOW UP; FRUCTOSE RESTRICTION; HISPANIC; HUMAN; INSULIN CLEARANCE; INSULIN KINETICS; INSULIN METABOLISM; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAPERITONEAL FAT; LIPID LIVER LEVEL; LIPOGENESIS; MACRONUTRIENT; MALE; MASS FRAGMENTOGRAPHY; MEAL; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN INTAKE; SELF REPORT; SUBCUTANEOUS FAT; SUGAR INTAKE; ADMINISTRATION AND DOSAGE; CARBOHYDRATE DIET; COMPLICATION; DIAGNOSTIC IMAGING; GLUCOSE TOLERANCE TEST; INTRAABDOMINAL FAT; LIVER; METABOLISM; PATHOPHYSIOLOGY;

ADOLESCENT; AFRICAN AMERICANS; CHILD; DIETARY CARBOHYDRATES; FEMALE; FRUCTOSE; GLUCOSE TOLERANCE TEST; HISPANIC AMERICANS; HUMANS; INSULIN; INTRA-ABDOMINAL FAT; LIPOGENESIS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC SYNDROME X; PEDIATRIC OBESITY; SUBCUTANEOUS FAT;

EID: 85027050511     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.05.043     Document Type: Article

References (53)

1. Maersk, M., Belza, A., Stødkilde-Jørgensen, H., et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 95 (2012), 283–289.
2. Stanhope, K.L., Schwarz, J.M., Keim, N.L., et al. Consuming fructose-, not glucose-sweetened beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119 (2009), 1322–1334.
3. Pollock, N.K., Bundy, V., Kanto, W., et al. Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. J Nutr 142 (2012), 251–257.
4. Lim, J.S., Mietus-Snyder, M., Valente, A., et al. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 7 (2010), 251–264.
5. Stanhope, K.L., Schwarz, J.M., Havel, P.J., Adverse metabolic effects of dietary fructose: Results from recent epidemiological, clinical, and mechanistic studies. Curr Opin Lipidol 24 (2013), 198–206.
6. Yki-Järvinen, H., Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2 (2014), 901–910.
7. Perry, R.J., Samuel, V.T., Petersen, K.F., et al. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510 (2014), 84–91.
8. Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115 (2005), 1343–1351.
9. Mathieu, P., Boulanger, M.C., Després, J.P., Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk. Rev Endocr Metab Disord 15 (2014), 289–298.
10. Fabbrini, E., Magkos, F., Mohammed, B.S., et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci 106 (2009), 15430–15435.
11. Cali, A.M., De Oliveira, A.M.K.H., Chen, S., et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?. Hepatology 49 (2009), 1896–1903.
12. Sung, K.C., Kim, S.H., Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab 96 (2011), 1093–1097.
13. Birkenfeld, A.L., Shulman, G.I., Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59 (2014), 713–723.
14. Newton, K.P., Hou, J., Crimmins, N.A., et al. Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease. JAMA Pediatr, 170(10), 2016, e161971.
15. Hudgins, L.C., Parker, T.S., Levine, D.M., et al. A dual sugar challenge test for lipogenic sensitivity to dietary fructose. J Clin Endocrinol Metab 96 (2011), 861–868.
16. Jacome-Sosa, M.M., Parks, E.J., Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. Curr Opin Lipidol 25 (2014), 213–220.
17. Kim, M.S., Krawczyk, S.A., Doridot, L., et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest 126 (2016), 4372–4386.
18. Schwarz, J.M., Noworolski, S.M., Wen, M.J., et al. Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab 100 (2015), 2434–2442.
19. Lustig, R.H., Mulligan, K., Noworolski, S.M., et al. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity 24 (2016), 453–460.
20. Gugliucci, A., Lustig, R.H., Caccavello, R., et al. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. Atherosclerosis 253 (2016), 171–177.
21. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
22. Noworolski, S.M., Lam, M., Merriman, R.B., et al. Estimation of steatosis with MRS and MRI: validation with histology is confounded by differences in methodology. Radiology 264 (2012), 88–96.
23. Noworolski, S.M., Tien, P.C., Merriman, R., et al. Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver. Magn Reson Imaging 27 (2009), 570–576.
24. Food and Nutrition Board. Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). 2005, Institute of Medicine, Washington, DC.
25. Hellerstein, M.K., Christiansen, M., Kaempfer, S., et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 87 (1991), 1841–1852.
26. Matsuda, M., DeFronzo, R.A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999), 1462–1470.
27. Mari, A., Pacini, G., Murphy, E., et al. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diab Care 24 (2001), 539–548.
28. Sparacino, G., Pillonetto, G., Capello, M., et al. WINSTODEC: a stochastic deconvolution interactive program for physiological and pharmacokinetic systems. Comput Methods Programs Biomed 67 (2002), 67–77.
29. Magkos, F., Fraterrigo, G., Yoshino, J., et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab 23 (2016), 591–601.
30. Weiss, E.P., Albert, S.G., Reeds, D.N., et al. Calorie restriction and matched weight loss from exercise: independent and additive effects on glucoregulation and the incretin system in overweight women and men. Diab Care 38 (2015), 1253–1262.
31. Welsh, J.A., Karpen, S., Vos, M.B., Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988−1994 to 2007−2010. J Pediatr 162 (2013), 496–500.
32. Williams, K.H., Shackel, N.A., Gorrell, M.D., et al. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev 34 (2013), 84–129.
33. Widhalm, K., Ghods, E., Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes 34 (2010), 1451–1467.
34. 1H-MRS measured ectopic fat in liver and muscle in Danish lean and obese children and adolescents. PLoS One, 10, 2015, e0135018.
35. Lambert, J.E., Ramos−Roman, M.A., Browning, J.D., et al. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146 (2014), 726–735.
36. Burgert, T.S., Taksali, S.E., Dziura, J., et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91 (2006), 4287–4294.
37. Byrne, C.D., Targher, G., Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol 34 (2014), 1155–1161.
38. Lim, S., Meigs, J.B., Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol 34 (2014), 1820–1826.
39. Mager, D.R., Iñiguez, I.R., Gilmour, S., et al. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liverfunction, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). J Parenter Enteral Nutr 39 (2015), 73–84.
40. McGarry, J.D., Banting Lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002), 7–18.
41. Ouyang, X., Cirillo, P., Sautin, Y., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48 (2008), 993–999.
42. Savage, D.B., Choi, C.S., Samuel, V.T., et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 116 (2006), 817–824.
43. Kalia, H.S., Gaglio, P.J., The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities. Clin Liver Dis 20 (2016), 215–224.
44. Schwarz, J.M., Chiolero, R., Revelly, J.P., et al. Effects of enteral carbohydrates on de novo lipogenesis in critically ill patients. Am J Clin Nutr 72 (2000), 940–945.
45. Schwarz, J.M., Mulligan, K., Lee, J., et al. The effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab 87 (2002), 942–945.
46. Schwarz, J.M., Linfoot, P., Dare, D., et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77 (2003), 43–50.
47. Titchenell, P.M., Quinn, W.J., Lu, M., et al. Direct hepatocyte insulin signaling is required for lipogenesis but Is dispensable for the suppression of glucose production. Cell Metab 23 (2016), 1154–1166.
48. Postic, C., Girard, J., Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118 (2008), 829–838.
49. Templeman, N.M., Skovsø, S., Page, M.M., et al. A causal role for hyperinsulinemia in obesity. J Endocrinol 232 (2017), R173–R183.
50. Jia, G., DeMarco, V.G., Sowers, J.R., Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12 (2016), 144–153.
51. Rangan, A., Allman-Farinelli, M., Donohoe, E., et al. Misreporting of energy intake in the 2007 Australian Children's Survey: differences in the reporting of food types between plausible, under- and over-reporters of energy intake. J Hum Nutr Diet 27 (2014), 450–458.
52. Chalasani, N., Younossi, Z., Lavine, J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Gastroenterology 142 (2012), 1592–1609.
53. Suzuki, A., Abdelmalek, M.F., Schwimmer, J.B., et al. Association between puberty and features of nonalcoholic fatty liver disease. Nonalcoholic Steatohepatitis Clinical Research Network. Clin Gastroenterol Hepatol 10 (2012), 786–794.